Viewing Study NCT06608212


Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2025-12-26 @ 10:46 PM
Study NCT ID: NCT06608212
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-10
First Post: 2024-09-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United States
Sponsor: Bayer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-10-09
Start Date Type: ACTUAL
Primary Completion Date: 2025-12-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2024-09-19
First Submit QC Date: None
Study First Post Date: 2024-09-23
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-11-07
Last Update Post Date: 2025-11-10
Last Update Post Date Type: ESTIMATED